Elevated PCSK9 Levels in Untreated Patients With Heterozygous or Homozygous Familial Hypercholesterolemia and the Response to High‐Dose Statin Therapy

BACKGROUND: Proprotein convertase subtilisin kexin type 9 (PCSK9) is an enzyme that impairs low‐density lipoprotein cholesterol (LDL‐C) clearance from the plasma by promoting LDL receptor degradation. Patients with familial hypercholesterolemia (FH) have reduced or absent LDL receptors and should th...

Descripción completa

Detalles Bibliográficos
Autores principales: Raal, Frederick, Panz, Vanessa, Immelman, Andrew, Pilcher, Gillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647281/
https://www.ncbi.nlm.nih.gov/pubmed/23537802
http://dx.doi.org/10.1161/JAHA.112.000028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647281/
https://www.ncbi.nlm.nih.gov/pubmed/23537802
http://dx.doi.org/10.1161/JAHA.112.000028

Ejemplares similares